Commission Implementing Regulation (EU) 2024/2587 of 2 October 2024 granting a Union authorisation for the biocidal product family Divosan PAA products in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council
Commission Implementing Regulation (EU) 2024/2587of 2 October 2024granting a Union authorisation for the biocidal product family Divosan PAA products in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council(Text with EEA relevance)THE EUROPEAN COMMISSION,Having regard to the Treaty on the Functioning of the European Union,Having regard to Regulation (EU) No 528/2012 of the European Parliament and of the Council of 22 May 2012 concerning the making available on the market and use of biocidal productsOJ L 167, 27.6.2012, p. 1, ELI: http://data.europa.eu/eli/reg/2012/528/oj., and in particular Article 44(5), first subparagraph, thereof,Whereas:(1)On 21 December 2023, Diversey Europe Operations B.V. submitted to the European Chemicals Agency ("the Agency") an application in accordance with Article 43(1) of Regulation (EU) No 528/2012 and Article 4 of Commission Implementing Regulation (EU) No 414/2013Commission Implementing Regulation (EU) No 414/2013 of 6 May 2013 specifying a procedure for the authorisation of same biocidal products in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L 125, 7.5.2013, p. 4, ELI: http://data.europa.eu/eli/reg_impl/2013/414/oj) for Union authorisation of the same biocidal product family, as referred to in Article 1 of Implementing Regulation (EU) No 414/2013, named "Divosan PAA products", of product-types 2, 3 and 4, as described in Annex V to Regulation (EU) No 528/2012. The application was recorded under case number BC-CB091187-53 in the Register for Biocidal Products ("the Register"). The application also indicated the authorisation number of the related reference biocidal product family "Airedale PAA product family", authorised by Commission Implementing Regulation (EU) 2023/1200Commission Implementing Regulation (EU) 2023/1200 of 21 June 2023 granting a Union authorisation for the biocidal product family "Airedale PAA product family" in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L 159, 22.6.2023, p. 3, ELI: http://data.europa.eu/eli/reg_impl/2023/1200/oj) with the authorisation number EU-0028970-0000.(2)The same biocidal product family "Divosan PAA products" contains peracetic acid as the active substance, included in the Union list of approved active substances referred to in Article 9(2) of Regulation (EU) No 528/2012 for product-types 2, 3 and 4.(3)On 14 March 2024, the Agency submitted to the Commission its opinionECHA opinion of 14.3.2024 on the Union authorisation of the same biocidal product family "Divosan PAA products", Opinion number UBS-C-1719835-03-00/F, https://echa.europa.eu/opinions-on-union-authorisation. and the draft summary of the biocidal product characteristics ("SPC") of "Divosan PAA products" in accordance with Article 6 of Implementing Regulation (EU) No 414/2013.(4)In its opinion, the Agency concludes that the proposed differences between "Divosan PAA products" and the related reference biocidal product family "Airedale PAA product family" are limited to information which can be the subject of an administrative change in accordance with Article 11 of Commission Implementing Regulation (EU) No 354/2013Commission Implementing Regulation (EU) No 354/2013 of 18 April 2013 on changes of biocidal products authorised in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L 109, 19.4.2013, p. 4, ELI: http://data.europa.eu/eli/reg_impl/2013/354/oj)., and that based on the assessment of the related reference biocidal product family "Airedale PAA product family" and subject to compliance with the draft SPC, "Divosan PAA products" meets the conditions laid down in Article 19(1) and (6) of Regulation (EU) No 528/2012.(5)On 21 March 2024, the Agency transmitted to the Commission the draft SPC of "Divosan PAA products" in all the official languages of the Union in accordance with Article 44(4) of Regulation (EU) No 528/2012 and based on the SPC of the related reference biocidal product family "Airedale PAA product family".(6)The Commission concurs with the opinion of the Agency and considers it therefore appropriate to grant a Union authorisation for the same biocidal product family "Divosan PAA products".(7)The expiry date of this authorisation should be aligned with the expiry date of the authorisation of the related reference biocidal product family "Airedale PAA product family".(8)The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Biocidal Products,HAS ADOPTED THIS REGULATION: